Product Information

OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.1168 per ML under NDC 65162064978. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Sep 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG/5 ML SUSP

Oxcarbazepine
$0.1168per ML

Strength

300 mg/5mL

NDC

65162064978

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202961

FDA Approved

9/17/2012

TE Code

AB

On Market Since

6/4/2012

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1168 per ML
All-time high$0.5873 (Feb 12, 2014)
All-time low$0.1168 (Aug 19, 2026)
52-week high$0.1754
52-week low$0.1168
Median price$0.3658
Average price$0.3714
Largest weekly change+66.8% (Jun 19, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-4.6%

1M

-4.6%

3M

-7.5%

6M

-18.1%

1Y

-33.5%

3Y

-66.8%

5Y

-71.2%

All

-79.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals LLC, is $0.1168 per ML (NDC 65162064978), effective Aug 19, 2026.

How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 79.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1168 (Aug 19, 2026) to a high of $0.5873 (Feb 12, 2014), with a median of $0.3658 per ML.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?

OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 65162064978) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.